“There was a dip in the rural demand and post the harvest, the high commodity prices and due to the wedding season overall, there was a goo...

“There is a one-off gain of almost Rs 149 crore on account of the pre redemption of the preference shares. Margins have been slightly sober...

The youngest chairman of Dabur, Amit Burman said his focus would be to enhance science-based ayurveda products, premiumisation, rural distr...

There is a kind of devotion to these brands, something that makes them the undisputed market leaders in India.

Patanjali's rivals retooled their portfolios with their natural-herbal products at similar price points.

It will take us three to four years to scale the businesses up to Rs 100-crore level each, says the CEO

The reason behind the decline could be consumer fatigue and FMCG companies like Colgate, HUL investing heavily in natural products to lure ...

Last year, BSF, the about 2.5 lakh personnel-strong force, had got trained over 2,000 of its jawans and officers at Ramdev's Patanjali inst...

Dabur India CFO Lalit Malik said playing the pricing game in the segment will not pay in the long run despite consumers' tendency to look a...

BSE FMCG index has lost over 11% in the past month, with many of its constituents falling as much as 23% as the competitive intensity from ...

Patanjali clocked revenues of about Rs 450 cr in fiscal year 2012, but analysts reckon that it could reach nearly Rs 5k cr in sales by the ...

Baba Ramdev’s Patanjali products are hurting volume growth of these companies, while margin growth that came from lower raw material prices...

Patanjali Ayurved is appealing to shopkeepers "to give prominence to products on shelves", because it "will help in fulfilling the dream of...

In shampoos, sales of Ayurvedic brands more than doubled to 194 per cent, while for MNCs, it declined to 15 per cent from 21 per cent earli...

Big Bazaar, Reliance Retail & Spencer’s Retail say Patanjali products among their top-selling brands.

To start with, the Burman family-led company with sales of around Rs 7,800 crore, will beef up its women's healthcare range.

Patanjali’s revenue grew at an extraordinary pace – a CAGR of 64.7 per cent over FY12-15 – which has made brokerages get excited about the ...